Duality Biologics
- Biotech or pharma, therapeutic R&D
DualityBio is an emerging leader in developing next generation ADCs for oncology and autoimmune diseases. DualityBio successful listed on HKEX on April 15th by completing an IPO raise of $211mn.
Address
ShanghaiShanghai
China
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}